Neuroleptic malignant syndrome (NMS) is a rare but serious side effect of antipsychotic medications that are often prescribed to treat a wide variety of mental disorders. This syndrome, which is also sometimes called neuroleptic syndrome or malignant syndrome, affects the body's nervous system and can have severely debilitating neurological, physical, and psychological consequences. While the exact cause is not completely understood, NMS is often brought on by the sudden or excessive use of antipsychotic medications. Those who are at highest risk for developing NMS are individuals who have recently changed their dosage of antipsychotic drugs, those with pre-existing medical or neurological conditions, the elderly, and people with a family history of NMS. The most common symptoms of this disorder include muscular rigidity, elevated fever, autonomic dysfunction, tremor, and altered mental status. It is important to note that not all of these symptoms have to be present in order for a diagnosis to be made. Treatment for NMS includes stopping the antipsychotic medication that triggered the syndrome, treating symptoms with antipyretic agents and benzodiazepines, and providing supportive care, such as fluids, nutrition, and ventilation if necessary. In some cases, patients may require the use of other medications to reduce their muscle rigidity and manage their psychological symptoms. It is important to recognize the signs of NMS, as it can be life-threatening if left untreated. Anyone taking an antipsychotic medication should be aware of the risk associated with this disorder and seek medical attention immediately if any of the NMS symptoms arise. Early diagnosis and prompt treatment are the key to a complete recovery.
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : The role of beliefs, perception, and behavioural patterns in the evolution of psychophysical disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States
Title : Cervical stenosis-induced chronic cerebrospinal fluid flow restriction as a contributing cause of dementia
Joe Sam Robinson, Mercer University, United States